期刊名称：THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
ISSN: 2153-7658 • Online ISSN: 2153-7933
OVERVIEW
Therapeutic Hypothermia and Temperature Management is the first and only journal to cover all aspects of hypothermia and temperature considerations relevant to this exciting field, including its application in cardiac arrest, spinal cord and traumatic brain injury, stroke, burns, and much more. The Journal provides a strong multidisciplinary forum to ensure that research advances are well disseminated, and that therapeutic hypothermia is well understood and used effectively to enhance patient outcomes. Novel findings from translational preclinical investigations as well as clinical studies and trials are featured in original articles, state-of-the-art review articles, protocols and best practices.
Therapeutic Hypothermia and Temperature Management coverage includes:
- Temperature mechanisms and cooling strategies
- Protocols, risk factors, and drug interventions
- Intraoperative considerations
- Post-resuscitation cooling
- ICU management
Therapeutic Hypothermia and Temperature Management is under the editorial leadership of Editor-in-Chief W. Dalton Dietrich, III, PhD, The Miami Project to Cure Paralysis, University of Miami; European Editor Hans Friberg, MD, PhD, Lund University; Australasian Editor, Stephen Bernard, MD, The Alfred Hospital; and other leading investigators. View the entire editorial board.
Audience: Emergency physicians, cardiologists, neurologists, anesthesiologists, critical care intensivists, cardiac intensivists, physicians, pediatricians, neurosurgeons, cardiac surgeons, EMS directors, nurses, interventional cardiologists, and infectious disease specialists, among others.
Indexed/Abstracted in:MEDLINE; PubMed; PubMed Central; Science Citation Index Expanded; Journal Citation Reports/Science Edition; EMBASE/Excerpta Medica; Scopus
Instructions to Authors
AIMS and SCOPES:
Therapeutic Hypothermia and Temperature Management is a peer-reviewed journal covering all aspects of hypothermia and temperature considerations relevant to this exciting field. Novel findings from translational preclinical investigations as well as clinical studies and trials will be featured. The journal publishes original articles, state-of-the-art review articles, protocols and best practices.
Manuscripts must be submitted online using the following URL:
http://mc.manuscriptcentral.com/hypothermia
Please read all the instructions to authors before submitting.
Language must conform to acceptable English usage and syntax. The contents must be clear, accurate, coherent, and logical. In accepting or rejecting a manuscript, the editors will also consider its originality, teaching value, and validity.
Manuscripts should not exceed approximately 4,000 words. To facilitate a quick review of manuscripts, authors are encouraged to suggest names of five potential reviewers with complete contact information when the manuscript is submitted.
PUBLICATION ETHICS AND MALPRACTICE STATEMENT
Study Design and Ethics
Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) should be required for all studies involving people, medical records, and human tissues. For those investigators who do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.
Animal experiments should require full compliance with local, national, ethical, and regulatory principles, and local licensing arrangements.
Definitions of Scientific Misconduct
Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).
Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:
- Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
-
Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.
-
Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
-
Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
-
Material failure to comply with legislative and regulatory requirements affecting research:
Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
- Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
- Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
-
Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.
- Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.
Responding to Allegations of Possible Misconduct
The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.
When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.
Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.
If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.
All allegations will be kept confidential.
For technical information on using Manuscript Central, contact Patricia Meravy at (914) 740-2132 or PMeravy@liebertpub.com
Manuscript Submission and Review
Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title. Published manuscripts become the sole property of the Journal and will be copyrighted. By submitting a paper to the Journal, the author (or authors) agrees to each of the above conditions. In addition, the author (or authors) explicitly assigns any copyrighted ownership he/she (or they) may have in such paper to the Journal.
Preparation of Manuscripts
Papers must be submitted via upload in a word processing format, preferably in Microsoft Word. Please do not include artwork within the text document. Figures and tables should be supplied in separate files, be labeled clearly, and should be in TIFF or EPS formats. Please see the Illustrations section for further details on art submission.
All copy must be double-spaced, including text, footnotes, references, legends, and tables. Text references must be supplied in sequence for all tables and figures. The title page should carry the full paper title, followed by the authors’ names, degrees, and where the work was performed. Please indicate the corresponding author.
An abstract should accompany every original paper. The abstract should appear on a separate page and should be at least 150 but not more than 300 words long. It should consist of factual information and not generalities (the problem investigated, the method used, the results obtained, and the conclusions reached). A brief introduction, materials and methods, results, discussion, acknowledgments, and reference sections should follow. At the conclusion of the references, the name and complete address of the reprint author should appear.
Correspondence and brief communications are published at the discretion of the editors as space permits. They should be double-spaced, and must not exceed 500 words in length.
References
The references must be double-spaced and must be cited in alphabetical order (by author), not numerical order. In-text citations should be in name, date format, and in parentheses.) The author is responsible for the accuracy and completeness of the references.
Examples:
Journal:**
Povlishock JT, Wei EP. Posthypothermic Rewarming Considerations following traumatic brain injury. J Neurotrauma 2009;26:333–340.
[In-text citation sample: (Povlishock, 2009).]
**Abbreviate journal names according to the style of Medline.
Chapter in a Book:
Yenari MA, Wijman CAC, Steinberg, GK Effects of Hypothermia on Cerebral Metabolism, Bloodflow, and Autoregulation. In: Therapuetic Hypothermia. Mayer SA, Sessler DI (eds). New York, NY: Informa Healthcare . 2004: pp. 141-178.
[In-text citation sample: (Yenari, 2004).]
Book:
Tisherman S, Sterz FH. Therapeutic Hypothermia. New YorkNY: Springer. 2005.
[In-text citation sample: (Tisherman, 2005).]
Statistical Analysis
If a statistical analysis is done, an explanation of how it was performed must be stated at the end of the section preceding results. Unusual or complex methods of analysis should be referenced.
Illustrations
Please follow these guidelines for submitting figures:
- Do NOT embed art files into a Word or PDF document. Figures provided in this format cannot be used for production purposes.
- Line illustrations should be submitted at 600 dpi.
- Halftones and color should be submitted at a minimum of 300 dpi.
- Save as either TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process. To ensure proper print quality, please submit only TIFF or EPS files.
- Color art must be saved as CYMK—not RGB. (NB: If files are submitted, the files will be converted to CYMK and some color variation will occur.)
- Black and white art must be submitted as grayscale—not RGB.
- Do NOT submit PowerPoint, PDF, Bitmap, or Excel figure or table files.
- When naming your figure and table files, please label them with the main author’s last name, followed by a period (.), and then list the figure number. Ex: Smith.Fig1; Smith.Table1.
Additional Information about Converting Figure Files:
Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
- All files should be scanned at 100% size
- 300 dpi
- Final color mode: CMYK
- Save file as: .TIFor .EPS
If you need directions on how to convert a PowerPoint slide to acceptable format go to: www.liebertpub.com/MEDIA/pdf/ppconvert.pdf
IMPORTANT:
Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
Permissions
Illustrations taken from other publications must be acknowledged by a complete credit line in the legend. The publisher’s letter of permission should be submitted to Therapeutic Hypothermia and Temperature Management.
Disclosure Statement
Immediately following the Acknowledgments section, include a section entitled ‘‘Author Disclosure Statement.’’ This text must be part of your actual manuscript file. In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals at www.icmje.org/roles_e.html for further guidance. If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’
Page Proofs
An e-mail containing a link to the PDF file of the page proof is sent to the corresponding author. The proof should be read carefully and returned promptly to the publisher with the author’s approval and/or corrections.
Reprints
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Tel: (914) 740-2100; Fax: (914) 740-2101; E-mail: info@liebertpub.com; Website: www.liebertpub.com.
Editorial Board
Editor-in-Chief
W. Dalton Dietrich, III, PhD
Scientific Director, The Miami Project to Cure Paralysis
Kinetic Concepts Distinguished Chair in Neurosurgery
Professor of Neurological Surgery, Neurology and
Cell Biology and Anatomy
University of Miami
Leonard M. Miller School of Medicine
Lois Pope LIFE Center
Miami, FL 33136-1060
hbramlett@med.miami.edu
European Editor
Hans Friberg, MD, PhD
Lund University
Lund, Sweden
Australasian Editor
Stephen Bernard, MD
The Alfred Hospital
Victoria, Australia
Managing Editor
Helen M. Bramlett, PhD
University of Miami Miller School of Medicine
hbramlett@med.miami.edu
Arctic Challenge Editor
Mary Kay Bader, MSN, RN
Mission Hospital
Mission Viejo, CA
Editorial Board
Benjamin S. Abella, MD
University of Pennsylvania
Philadelphia, PA
Guadalupe Castillo Abrego, MD
Caja del Seguro Social Hospital, PTY
Panamá City, Panamá
P. David Adelson, MD, FACS, FAAP
Phoenix Children's Neuroscience Institute
Phoenix, AZ
Neeraj Badjatia, MD, MSc
University of Maryland
Baltimore, MD
Lance B. Becker, MD
Northwell Health
Manhasset, NY
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FNCS
Virginia Commonwealth University
Richmond, VA
M. Ross Bullock, MD, PhD
University of Miami Miller School of Medicine
Miami, FL
Fred Colbourne, PhD
University of Alberta
Alberta, Canada
Simon Dixon, MBChB, FRACP, FACC
William Beaumont Hospital
Royal Oak, MI
David Erlinge, MD, PhD
Lund University
Lund, Sweden
Donna Ferriero, MD
University of California
San Francisco, CA
Barth A. Green, MD
University of Miami Miller School of Medicine
Miami, FL
Eric Harrison, MD
IASIS Healthcare Inc.
Tampa, FL
Nariyuki Hayashi, MD
Nihon University
Tokyo, Japan
Daniel I. Herr, MD
University of Maryland
Baltimore, MD
Michael Holzer, MD
Medical University of Vienna
Vienna, Austria
Michal Horowitz PhD
The Hebrew University
Jerusalem, Israel
Chien-Hua Huang, MD, PhD
National Taiwan University Medical College and Hospital
Taipei, Taiwan
Jamie Hutchison, MD
University of Toronto
Toronto, Canada
Ji-Yao Jiang, PhD, MD
Jiaotong University, School of Medicine
Shanghai, China
Emanuela Keller, MD
University Hospital
Zurich, Switzerland
Francis Kim, MD
University of Washington
Seattle, WA
Patrick M. Kochanek, MD
University of Pittsburgh
Pittsburgh, PA
Rainer Kollmar, MD
Darmstadt Academic Hospital
Darmstadt, Germany
Kiwon Lee, MD, FACP, FAHA, FCCM
The University of Texas Medical School at Houston
Houston, TX
Liping Liu, MD, PhD
Capital Medical University
Beijing, China
Justin B. Lundbye, MD, FACC
Hospital of Central Connecticut
New Britain, CT
Patrick D. Lyden, MD, FAAN
Cedars-Sinai Medical Center
Los Angeles, CA
Donald W. Marion MD, MSc
The Defense and Veterans Brain Injury Center
Silver Spring, MD
Stephan Anthony Mayer, MD
Icahn School of Medicine at Mount Sinai
New York, NY
Michael R. Mooney, MD
Minneapolis Heart Institute Foundation
Minneapolis, MD
Ken Nagao, MD
Nihon University School of Medicine
Tokyo, Japan
Marko Noc, MD, PhD
University of Ljubljana
Ljubljana, Slovenia
David O. Okonkwo, MD, PhD
University of Pittsburgh
Pittsburgh, PA
William M. Parham, III, MD
Abbott Northwestern Hospital
Minneapolis, MN
Kyu Nam Park, MD, PhD
The Catholic University of Korea
Seoul, Korea
Kees H. Polderman, MD, PhD
University of Pittsburgh
Pittsburgh, PA
John T. Povlishock, PhD
Virginia Commonwealth University
Richmond, VA
Fred Rincon, MD, MSc, MBE
Thomas Jefferson University
Philadelphia, PA
Hyun Wook Ryoo, MD, PhD
Kyungpook National University Hospital
Daegu, Korea
Stefan Schwab, MD, PhD
University Hospital Erlangen
Erlangen, Germany
Seetha Shankaran, MD
Wayne State University
Detroit, MI
Hyung Soo Han, MD, PhD
Kyungpook National University School of Medicine
Daegu, Korea
Eldar Søreide, MD PhD
Stavanger University Hospital
Stavanger, Norway
Marianne Thoresen MD, PhD
University of Bristol
Bristol, United Kingdom
David S. Warner, MD
Duke University
Durham, NC
Tadeusz Wieloch, PhD
Lund University
Lund, Sweden
Midori A. Yenari, MD
University of California
San Francisco, CA
|
